Organic Stereochemistry. Part 8

This review terminates our general presentation of the principles of stereochemistry with special reference to the biomedicinal sciences. Here, we discuss and illustrate the principles of prostereoisomerism, and apply these to product and substrate? product stereoselectivity in drug metabolism. The review begins with an overview of the concept of prostereoisomerism, discussing such aspects as homotopic, enantiotopic, and diastereotopic groups and faces. The main part of this review is dedicated to drug and xenobiotic metabolism. Here, the concept of prostereoisomerism proves particularly helpful to avoid confusing metabolic reactions in which an existing stereogenic element (e.g., a stereogenic center) influences the course of the reaction (substrate stereoselectivity), with metabolic reactions which create a stereogenic element (almost always a stereogenic center; product stereoselectivity). Specifically, examples of product stereoselectivity will be taken from functionalization reactions (so‐called phase‐I reactions) and conjugation (so‐called phase‐II reactions). Cases where stereoisomeric substrates show distinct product stereoselectivities (substrate? product stereoselectivity) will also be presented.     

Organic Stereochemistry. Part 4

This Part 4 continues a general presentation of the principles of stereochemistry with special reference to medicinal compounds and their interactions with biological systems. Here, we discuss and illustrate two major aspects of conformational isomerism, namely a) the concept of torsional isomerism about single bonds, and b) the intertwined conformational and configurational aspects of the stereochemistry of cyclic systems. The review begins with a brief reminder of the history and thermodynamics of conformational isomerism, and goes on to explain and illustrate the conventions and graphical representations used for conformers. Examples are then examined, beginning with ethane, the simplest one, and building up to more complex cases, documenting the attractive or repulsive role of substituents. A similar approach is applied when dealing with cyclic systems, although here the presentation necessarily takes into account configurational aspects specific to cyclic systems. The pharmacological implications of the concepts discussed here will be presented in Part 6.     

Organic Stereochemistry. Part 7

This review continues a general presentation of the principles of stereochemistry with special emphasis on the biomedicinal sciences. Here, we discuss and illustrate the phenomenon of substrate stereoselectivity in biochemistry (endogenous metabolism) and principally in xenobiochemistry or drug metabolism. The review begins with an overview of the stereoselective processes occurring in the biomedicinal sciences. The general rule is for distinct stereoisomers, be they enantiomers or diastereoisomers, to elicit different pharmacological responses (Part 5), to a lesser extent be transported with different efficacies (Part 5), and to be metabolized at different rates (this Part). In other words, biological environments discriminate between stereoisomers both when acting on them and when being acted upon by them. The concept of substrate stereoselectivity describes this phenomenon in endogenous biochemistry and xenobiotic metabolism, as discussed and illustrated in the present Part. The sister concept of product stereoselectivity will be presented in Part 8.